| 0 (0%) | 11-11 15:57 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.1 | 1-year : | 2.55 |
| Resists | First : | 1.8 | Second : | 2.19 |
| Pivot price | 1.48  |
|||
| Supports | First : | 1.16 | Second : | 0.97 |
| MAs | MA(5) : | 1.28 |
MA(20) : | 1.5 |
| MA(100) : | 1.4 |
MA(250) : | 1.88 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 12.3 |
D(3) : | 8.3 |
| RSI | RSI(14): 43.2 |
|||
| 52-week | High : | 12.85 | Low : | 0.64 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CTXR ] has closed above bottom band by 21.8%. Bollinger Bands are 19.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.3 - 1.31 | 1.31 - 1.31 |
| Low: | 1.22 - 1.22 | 1.22 - 1.23 |
| Close: | 1.27 - 1.28 | 1.28 - 1.29 |
Mon, 10 Nov 2025
Can a trend reversal in CTXR lead to recovery - Forecast Cut & Capital Efficient Trade Techniques - newser.com
Mon, 10 Nov 2025
Reversal indicators forming on CTXR stock - Weekly Trade Recap & Risk Controlled Swing Alerts - newser.com
Mon, 10 Nov 2025
Reversal indicators forming on CTXR stock - July 2025 Sentiment & Fast Momentum Entry Tips - newser.com
Mon, 10 Nov 2025
Will CTXR stock recover faster than market - Quarterly Trade Report & High Win Rate Trade Tips - newser.com
Sun, 09 Nov 2025
What analyst consensus says on CTXR stock - July 2025 Rallies & Real-Time Volume Analysis - newser.com
Tue, 28 Oct 2025
When Will Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Breakeven? - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 18 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 3 (%) |
| Held by Institutions | 5.7 (%) |
| Shares Short | 1,580 (K) |
| Shares Short P.Month | 1,030 (K) |
| EPS | -4.87 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.48 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -22.9 % |
| Return on Equity (ttm) | -54.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -2.23 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -21 (M) |
| Levered Free Cash Flow | 18 (M) |
| PE Ratio | -0.27 |
| PEG Ratio | 0 |
| Price to Book value | 0.28 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|